英美德日药品监管机构设置模式比较及启示  

Comparison and enlightenment of drug regulatory institutions between Britain,America,Germany and Japan

作　　者：鄢广 Yan Guang(School of Law,Guiyang University,Guiyang550005,China)

机构地区：[1]贵阳学院法学院,贵阳550005

出　　处：《中国卫生法制》2023年第4期54-58,71,共6页China Health Law

基　　金：贵阳学院博士科研启动经费支持项目“中英卫生行政法制度比较研究”(2019039510503)阶段性成果。

摘　　要：英美德日药品监管机构设置均属于大健康部门辖下的以独立监管机构为主的体系,重视专业监管和合作共管,在药品监管方面具有先进性。通过查阅四国相关资料,概述了四国药品监管机构体系的组织架构和特点,比较了英美德日四国的药品监管机构的设置特征,为我国今后药品监管体制改革提供参考。The regulatory system in Britain,Germany and Japan is a system of independent health regulators supervised by the Department of Health.It attaches importance to professional supervision and co-management.It has advanced significance in drug supervision and has certain reference significance.By consulting the relevant materials of the four countries,this paper summarized the organizational structure and characteristics of the drug regulatory institution system of the four countries,so as to provide reference for the reform of drug regulatory system in China in the future.

关 键 词：比较视角 大部制 机构设置 启示 

分 类 号：D902[政治法律—法学理论]